3rd Quarter - Report — AVANIR PHARMACEUTICALS for AVANIR PHARMACEUTICALS (2017)

Firm

AVANIR PHARMACEUTICALS

Client

AVANIR PHARMACEUTICALS

Income

—

Expenses

$80,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Long term care regulations; out of pocket costs.

Lobbyist	Covered position, as disclosed
CRYSTAL LYNN VANUCH	Head of Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

Alzheimer's research funding in the FY18 House and Senate Labor, HHS and Education Appropriations bills HR 3358 and S. 1771.

Lobbyist	Covered position, as disclosed
CRYSTAL LYNN VANUCH	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3358 (115th), S. 1771 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.